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Rheumatoid arthritis (RA) is an autoimmune disease characterized by inﬂammation followed
by tissue rebuilding or ﬁbrosis. A failure by the body to regulate inﬂammation effectively is
one of the hallmarks of RA. The interaction between the external environment and the
human host plays an important role in the development of autoimmunity. In RA, the
observation of anti-cyclic citrullinated peptide antibodies (ACPA) to autoantigens is well
recognized. Citrullination is a post-translational modiﬁcation mediated by peptidyl arginine
deiminases, which exist in both mammalian and bacterial forms. Previous studies have
shown how proteins expressed in the human extracellular matrix (ECM) acquire properties
of damage-associated molecular patterns (DAMPs) in RA and include collagens, tenascin-
C, and ﬁbronectin (FN). ECM DAMPs can further potentiate tissue damage in RA. Recent
work has shown that citrullination in RA occurs at mucosal sites, including the oral cavity
and lung. Mucosal sites have been linked with bacterial infection, e.g., periodontal disease,
where exogenous pathogens are implicated in the development of autoimmunity via an
infectious trigger. Proteases produced at mucosal sites, both by bacteria and the human
host, can induce the release of ECM DAMPs, thereby revealing neoepitopes which can
be citrullinated and lead to an autoantibody response with further production of ACPA. In
this perspectives article, the evidence for the interplay between the ECM and bacteria at
human mucosal surfaces, which can become a focus for citrullination and the development
of autoimmunity, is explored. Speciﬁc examples, with reference to collagen, ﬁbrinogen,
and FN, are discussed.
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INTRODUCTION
Rheumatoid arthritis (RA) is an immune-mediated inﬂammatory
disease. It is often associated with chronic disability, early mor-
tality, systemic complications, and places a high socioeconomic
burden on society as a whole (McInnes and Schett, 2011). In the
last fewdecades therehavebeen improved treatments forRA,based
on immune-modulation of inﬂammatory pathways. However, up
to one-third of people with RA continue to experience high disease
activity, despite treatment with strong immunomodulatory drugs
such as tumour necrosis factor (TNF) inhibitors, methotrexate,
and corticosteroids (Scott et al., 2010). An improved understand-
ing of disease pathophysiology is therefore essential to develop
new treatments to address this unmet need.
The development of RA results from a complex interplay
between genotype, environment, and lifestyle factors such as
smoking (Mahdi et al., 2009). An important clinical aspect in
the diagnosis of RA includes the detection of anti-citrullinated
peptide antibodies (ACPA) to auto-antigens. Citrullination, also
known as demimination, is the conversion of the amino acid argi-
nine in a protein into the amino acid citrulline. Enzymes called
peptidylarginine deiminases (PADs) replace the primary ketamine
group (=NH) by a ketone group (=O). Citrullination is involved
in regulation of development during embryogenesis and in
demination-regulated gene expression through histone modiﬁca-
tions. Citrulline is not one of the standard 20 amino acids encoded
by DNA in the genetic code; it is the result of a post-translational
modiﬁcation. The immune system often attacks citrullinated
proteins, thereby leading to autoimmune phenomena in RA.
Twin studies have showna concordance rate forRAof 15 to 30%
among monozygotic twins and 5% among dizygotic twins (13).
Genome-wide association analyses have identiﬁed immune regu-
latory factors that may underlie the disease; including PTPN22
among the single nucleotide polymorphisms (SNPs) identiﬁed
(Wellcome Trust Case Control Consortium, 2007). An associa-
tion with HLA-DRB1 has been established for RA patients who
are positive for rheumatoid factor or ACPA (Gregersen et al.,
1987). In keeping with the role of HLA-DRB1 in antigen pre-
sentation, a number of studies over the last two decades have
shown that auto-reactive immune responses are mediated by
T-cell repertoire selection, antigen presentation, or changes in
peptide afﬁnity (Panayi, 2006). The shared epitope (SE), carried
by the vast majority of RA patients, is a 5-aa sequence motif
in the third allelic hypervariable region of the HLA-DRβ chain.
Proposed explanations for the link between RA and the SE include
molecular mimicry of the SE by microbial proteins, increased T
cell senescence induced by SE-containing HLA molecules and a
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potential pro-inﬂammatory signaling function that is unrelated to
the role of the SE in antigen recognition (Weyand and Goronzy,
1990; De Almeida et al., 2010).
Gene–environment interactions are also important in RA
development. Smoking and other environmental risks to the lung,
such as silica exposure, increase the risk of RA in people with sus-
ceptibilityHLA-DR4 alleles (Symmons et al., 1997; Klareskog et al.,
2008). Smoking and HLA-DRB1 alleles synergistically increase
the risk of developing the anti-citrullinated protein antibodies
(ACPA) that are present in the majority of patients with RA (Li
et al., 2007). It has therefore been proposed that environmen-
tal stress in the lung or other mucosal surfaces may promote
post-translational modiﬁcations through activation of peptidyl
arginine deiminase, type IV (PADIV), which can cause citrulli-
nation of mucosal proteins. Loss of tolerance to the neoepitopes
generated by citrullination can be detected clinically in peoplewith
RA by the ACPA response (Vincent et al., 1999).
For many years, it has been recognized that infectious agents
such as cytomegalovirus, Escherichia coli, Epstein Barr virus, par-
vovirus, and proteus species may play a role in the development
of RA. Recently, the oral pathogen Porphyromonas gingivalis
has been implicated in the pathogenesis of RA (Mikuls et al.,
2014). Products of infectious agents, e.g., heat shock proteins
and enzymes responsible for citrullination have been shown in
several models to induce immune reactivity. For example, sev-
eral citrullinated autoantigens can be identiﬁed in assays to test
for ACPA, keratin, ﬁbrinogen, ﬁbronectin (FN), collagen, and
vimentin (van der Woude et al., 2010). Many of the proteins
described form part of the extracellular matrix (ECM) com-
mon to many structures in the joint, lung, skin, and mucosal
tissue. Damage-associated molecular patterns (or DAMPSs) are
molecules that can initiate and perpetuate the immune response
in the non-infectious inﬂammatory response. Molecules includ-
ing ﬁbrinogen and FN, which are abundant in the arthritic joint,
have been implicated described as DAMPs in RA pathophysi-
ology and are susceptible to citrullination. It is also possible
that cleavage of DAMPs by proteases during the arthritic process
may lead to exposure of neoepitopes which are then suscepti-
ble to a heightened autoimmune response. Although unifying
mechanisms for the link between infection and RA autoim-
munity are not entirely established, the theory of molecular
mimicry has been proposed (van Heemst et al., 2014). The for-
mation of immune complexes during infection may trigger the
induction of rheumatoid factor, which is a high afﬁnity autoan-
tibody against the Fc portion of immunoglobulin, often used
in the diagnosis of RA (De Rycke et al., 2004). A link has been
described between RA and periodontal disease (PD): Porphy-
romonas gingivalis produces bacterial peptidylarginine deiminase
(PAD) which can promote citrullination of mammalian proteins
(Wegner et al., 2010). Recently, the gastrointestinal microbiome
has also been implicated in the development of autoimmunity
(Scher et al., 2012).
ECM INTERACTIONS IN RA
In the sections below, we discuss the role of common ECM pro-
teins found not only in the arthritic joint, but also highly expressed
by mucosal surfaces including the lung, mouth, and gut. We
discuss how such ECM proteins may be cleaved and citrullinated
at mucosal surfaces, thereby leading potentially to the breakdown
of tolerance and the development of autoimmunity in RA.
COLLAGENS
Collagens comprise a superfamily of ECM proteins which provide
a structural framework for many connective tissues. Collagens
can be divided into several families or groups based on their
exon structure, containing several homologous genes encoding
polypeptides that have domains with similar sequences. All colla-
gens have domains with a triple helical conformation (Bella et al.,
1994) and are a major constituent of connective tissue. Collagen
ﬁbrils composed primarily of type II and XI collagen provide a
structural framework to hyaline cartilage (Li et al., 2007), and type
I/III and V collagens are a major constituent of skin, tendon, liga-
ments and bone, demonstrating how the major constituents of the
joint require collagen for their structural integrity. Mutations in
COL2A1 cause a spectrumof chondrodysplasias, including achon-
drogenesis II, hypochondrogenesis, spondyloepiphyseal dysplasia,
and Kniest and Stickler syndromes (Mundlos and Olsen, 1997).
Type II collagen can be injected peripherally to induce RA in
murine arthritis in the collagen-induced arthritis (CIA)-model
(Williams, 2004), which is one of themost commonly usedmurine
models of inﬂammatory arthritis.
FIBRINOGENS
Fibrinogen is a soluble plasma protein. After cleavage by α-
thrombin, it is converted to ﬁbrin monomers (Blombäck, 1996).
Fibrin monomers self-associate to form an insoluble homopoly-
meric structure, the ﬁbrin clot. Fibrinogen can also bind to
platelets, contributes to the formation of ﬁbrin clots, as well as
endothelial cells and leukocytes and plays amultifaceted role in the
ECM response to injury. Fibrinogen expression is upregulated at
mucosal surfaces during injury, thus participating in inﬂammatory
responses. Congenital lack of ﬁbrinogen results in a bleeding dis-
order, while increased plasma levels are associatedwith heightened
arterial and venous thrombotic risk (Everse et al., 1998).
FIBRONECTIN
Fibronectin is an ECM glycoprotein present in tissues and body
ﬂuids that is involved in a range of processes, including cellular
differentiation, adhesion, migration, wound healing, and neo-
plastic transformation (Hynes and Yamada, 1982). FN comprises
the ECM in joint tissue, including the synovial membranes and
cartilage. Expression of FN is upregulated in arthritic diseases
including RA and osteoarthritis (Sofat et al., 2012). In addition,
FN fragments have been detected in cartilage from people with
RA and OA and are responsible for further cartilage matrix degra-
dation (Sofat et al., 2012). Citrullination of FN has been found in
RA synovial tissue (Chang et al., 2005) and antibodies to citrulli-
nated FN have been detected in people with RA (Van Beers et al.,
2012).
WHERE COULD CITRULLINATION TAKE PLACE? INSIGHTS
FROM MUCOSAL SURFACES
Antibodies to citrullinated peptide antigens are associated with
RA and predate disease onset in many cases (Ioan-Facsinay et al.,
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2008). Since RA autoantibodies often pre-date the development of
inﬂammation in the synovium, it is possible that primary citrul-
lination occurs outside the synovium. It has been suggested that
infectious agents release toxins such as lipopolysaccharide (LPS)
at mucosal surfaces, triggering an inﬂammatory response with
potential to cause citrullination of ECM. Citrullination may affect
ECM proteins found both at mucosal surfaces such as lung, oral
and gut mucosa, and in articulating joint tissue, including FN,
ﬁbrinogen, and collagen.
LUNG
Klareskog et al. (2008) suggested that the lung may be a site of cit-
rullination, where co-factors such as smoking and exposure to
LPS may result in altered immune status of the lung mucosa.
The lung is susceptible to inﬂammatory responses triggered by
infection and autoimmunity (Meyer, 2010). In addition to the
increased prevalence of ACPA in smokers (Meyer, 2010) there
is also increased ACPA prevalence in RA-related lung disease
(Ruiz-Esquide et al., 2012). Respiratory micro-organisms are also
linked to the development of RA (Perry et al., 2014).
To explore the link between inﬂammation and modiﬁcation
of the ECM matrix in the lung, we investigated the effect of pul-
monary LPS exposure on ECM expression in mice. Experiments
were performed using 6–8 weeks old female BALB/c mice. Mice
were anesthetized with isoﬂurane (in accordance with UK Home
Ofﬁce regulation), then 50 μL of 0.125 mg/kg LPS from E. coli
serotype 0127:B8 or saline control was administered intranasally.
Mice were sacriﬁced after 24 h: the lungs were dissected out
and ﬁxed for 4 h in 4% paraformaldehyde and washed before
embedding in parafﬁn wax. Our murine model showed an inﬂam-
matory response to LPS, with oedema, destruction of alveolar
architecture, and a cellular inﬁltrate (Figures 1A,B). For his-
tochemistry, lung tissue was sectioned into 4 μm slices which
were stained with haematoxylin and eosin or primary rabbit anti-
FN antibody. The expression of FN, an ECM molecule which is
expressed in the lung, was highly upregulated in LPS treated mice
vs. saline controls (n = 5 in each group). FN protein was detected
in the surrounding ECM of alveolar tissue, type II pneumo-
cytes, and the cellular inﬁltrate demonstrated by immunostaining
with primary anti-FN antibody followed by a secondary anti-
body conjugated with horseradish peroxidase by light microscopy
(Figure 1C).
To determine whether the increased FN expression observed in
the murine system was also relevant to human lung disease, we
investigated the expression of FN in bronchoalveolar lavage ﬂuid
(BALF) from people with chronic severe asthma and/or COPD.
BALF was probed for FN using SDS-PAGE and Western blot-
ting (Figure 1D). We observed expression of full-length FN in
all samples tested from human BALF with asthma and COPD. In
addition, we observed increased expression of fragmented FN in
all samples tested, suggesting cleavage of FN during asthma and
COPD.A separate gel was run on SDS-PAGE, and samples of BALF
from subjects with mild asthma were analyzed by liquid chro-
matography mass spectrometry (LC-MS) on 1-D gels by in-gel
digestion (Figure 1E). Bands from SDS-PAGE were cut from the
gel (Figure 1E) and subjected to mass spectrometry demonstrat-
ing a typical signature of protein expression from BALF samples,
including alpha-1 antitrypsin, complement, immunoglobulin, FN
was also identiﬁed from samples mapping to the cell-binding
region and the C-terminal heparin-binding region of FN. These
FN regions identiﬁed in human BALF are the same regions as have
previously been implicated in mediating chronic inﬂammation in
arthritis (Sofat et al., 2012). Taken together, our ﬁndings show that
acute inﬂammation in mouse lung induces increased FN expres-
sion and that expression and fragmentation of FN can also be
demonstrated in human lung BALF extracts.
Other groups have described citrullination of FN in RA (Chang
et al., 2005). Upregulation of FN expression at mucosal surfaces
including the lung, as we have shown, may consequently con-
tribute to mechanisms of RA pathogenesis such as citrullination.
Our data showed increased FN expression in BALF samples and
fragmented forms of FN, which may represent fragmentation by
proteases. It is possible that FN and/or its fragments mediate
chronic inﬂammation during lung injury and result in citrulli-
nation in RA driven by cofactors such as smoking and the SE.
PERIODONTAL SURFACES
The oral mucosa contains an abundance of bacterial organisms in
health and disease. A strong link has been described between PD
and RA, giving rise to investigation of the oral microbiome in RA.
Recent work has suggested that environmental factors inﬂuenc-
ing autoimmunity include crosstalk between the human host and
oral/intestinal microbiomes. Several lines of investigation have
suggested a link between the oral microbes, PD and RA (Wegner
et al., 2010; Mikuls et al., 2014). Recent studies have shown that
people with RA have a high prevalence of PD. A genome sequenc-
ing approach using samples collected from the subgingival bioﬁlm
identiﬁed a number of organisms, includingAnaeroglobus gemina-
tus, Porphyromonas gingivalis, Prevotella, and Leptotrichia species
in people with new-onset RA (Scher et al., 2012).
We investigated the ability of oral microbes to modify ECM
proteins. Porphyromonas gingivalis, a known pathogen in PD
(strain W83 from ATCC) was cultured for 24 h under full anaero-
bic conditions (3M Concept Plus anaerobic incubator). Bacterial
supernatants were extracted and incubatedwith ECMsubstrates at
0.5 mg/ml at 37◦C,with collection of digestion products from 0 to
180 min after digestion. ECM substrates chosen for these exper-
iments were ﬁbrinogen, FN and type I collagen, as these ECM
proteins are found both in arthritic joints and in oral mucosa.
The cleavage patterns of ECM substrates were evaluated by SDS-
PAGEandWestern blotting in the presence and absence of selective
protease inhibitors.
We found that culture supernatants from P. gingivalis were
effective at cleaving all the substrates tested. At 37◦C the rate of
cleavage was: ﬁbrinogen 30 min for complete cleavage, FN was
180 min for complete cleavage and type I collagen was cleaved
at a slower rate over 180 min (Figure 2). Intermediate digestion
products for all three ECM proteins were demonstrated on SDS-
PAGE (Figure 2). Our results show that cleavage pattern of ECM
protein substrates was distinct for each of the substrates tested.
The varying cleavage patterns are likely to have been inﬂuenced
by the nature of the secreted proteases produced by P gingivalis,
and that the varying levels of protease expression produced by the
microorganism had a differing effect on the digestion pattern and
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FIGURE 1 | Expression of fibronectin (FN) in murine and human lung
tissue. (A) Experiments were performed using 6–8 weeks old female BALB/c
mice. Mice were anesthetized with isoﬂurane, then 50 μL of 0.125 mg/kg
LPS from Escherichia coli serotype 0127:B8 or saline control was
administered intranasally. Mice were sacriﬁced after 24 h: the lungs were
dissected out and ﬁxed for 4 h in 4% paraformaldehyde and washed before
embedding in parafﬁn wax. Our murine model showed an inﬂammatory
response to LPS, with oedema, destruction of alveolar architecture and a
cellular inﬁltrate (arrows indicate areas of inﬂammatory inﬁltrate). (B)The
cellular inﬂammatory inﬁltrate was quantiﬁed in ﬁve representative lung ﬁelds
and was compared between mice treated with LPS or saline control. (C)We
demonstrated the expression of FN, an ECM molecule in murine lung
harvested after LPS treatment. Expression of FN (increased brown staining
by horseradish peroxidase) was highly upregulated in LPS treated mice vs.
saline controls (n = 5 in each group). FN protein was detected in the
surrounding ECM of alveolar tissue, type II pneumocytes, and the cellular
inﬁltrate (arrows indicate perivascular staining of FN in lung ECM, alveolar
tissue, and pneumocytes). For immunohistochemistry, lung tissue was
sectioned into 4 μm slices which were stained with haematoxylin and eosin
or primary rabbit anti-FN antibody. FN antigen was detected using secondary
antibodies conjugated to horseradish peroxidase and analyzed by light
microscopy. (D) Expression of FN from bronchoalveolar lavage ﬂuid (BALF) is
shown in participant samples obtained with informed consent. Samples were
obtained from people with mild asthma (1–3) or chronic obstructive
pulmonary disease (COPD). SDS-PAGE was performed followed by
immunoblotting. TheWestern blot was treated with a primary antibody to
human FN (Sigma), with a secondary anti-rabbit antibody (Sigma) conjugated
to alkaline phosphatase for development. (E) Bands from samples 1–3 of
BALF from participants with mild asthma (D) were run separately on
SDS-PAGE, bands of interest were cut out and then subjected to analysis
using liquid chromatography mass spectrometry (LC-MS). Residues from
proteins identiﬁed from BALF samples are shown.
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FIGURE 2 | Cleavage of ECM proteins FN, fibrinogen, and type I
collagen by culture supernatants of Porphyromonas gingivalis.
Digestion patterns observed over a time course experiment from 0 up to
180 min was performed with culture supernatants from P. gingivalis
incubated with FN, ﬁbrinogen, and type I collagen, respectively. Digestion
patterns for FN (A), ﬁbrinogen (B), and type I collagen (C) are shown. For
FN (A), almost full cleavage was observed after 180 min, an effect which
was delayed in the presence of inhibitors KYT-1 and KYT-36. For ﬁbrinogen
(B), full cleavage was observed within 30 min. In contrast, with the
gingipain inhibitors, cleavage was not observed in a rapid manner and
intermediate cleavage products remained after 180 min of digestion in the
presence of KYT inhibitors. For type I collagen, slower cleavage was
observed, but was more rapid than without co-culture with P. gingivalis
supernatants, suggesting that all three ECM molecules tested are cleaved
more rapidly in the presence of P. gingivalis. Culture supernatants of the
anaerobe P. gingivalis (strain W83 from ATCC) were produced from 24 h
cultures using full anaerobic conditions (3M Concept Plus anaerobic
incubator). After culture, bacterial supernatants were extracted and
incubated with the substrates at 0.5 mg/ml at 37◦C, with collection of
digestion products from 0 to 180 min.
kinetics of speciﬁc protein substrates. In the presence of gingi-
pain inhibitors KYT-1 and KYT-36, cleavage of the substrates FN
and ﬁbrinogen was strongly inhibited, as demonstrated by the
persistence of digestion products in the presence of both pro-
tease inhibitors. Due to the likely varying inhibition of selective
proteases by speciﬁc inhibitors KYT-1 and KYT-36, we observed
differing inhibition patterns. However, as observed by the lack of
inhibition of complete cleavage of the substrates we tested, it is
likely that other proteases are also important in cleaving the sub-
strates tested. Based on our in vitro ﬁndings, it could be possible
that ECM substrates such as ﬁbrinogen, FN, and type I colla-
gen could be cleaved by proteases in the oral mucosa, giving rise
to neoepitopes which could then be available for citrullination.
Taken together, our ﬁndings raise the possibility that modiﬁca-
tion of ECM proteins in the oral mucosa by bacterial products
could drive production of autoantibodies against ECM proteins
expressed both in the oral mucosa and in arthritic joints. Inhibi-
tion of cleavage of oral ECM proteins may have potential as a new
therapeutic target in the management of RA.
CONCLUDING REMARKS
Our data and reports fromother groups demonstrate thatmucosal
surfaces express ECM DAMPS and that selective proteases can
cleave ECM substrates found in the lung and oral mucosa. Our
previous work has shown that ECM FN is upregulated in arthritic
cartilage (Sofat et al., 2012) and other groups have demonstrated
citrullinated FN inhibits apoptosis and promotes production of
pro-inﬂammatory cytokines inRA (Fan et al., 2012). Such ﬁndings
suggest that ECM proteins shared in the oral mucosa, lung, and
the arthritic joint may contribute to the development of autoim-
munity in RA. Future work to identify the proteases involved
in both cleavage and citrullination of autoantigens, which may
then serve to act as DAMPs, both in human and microbial
systems, will be crucial to our understanding of disease patho-
physiology in RA. Inhibition of cleavage of such substrates may
delay the production of ECM DAMPs that are targets for citrul-
lination in RA. Therapeutic strategies aimed at inhibiting such
cleavage of ECM substrates may be a novel therapeutic target
in RA.
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